Back to Search Start Over

Impact of Converting from Immediate-Release Tacrolimus to Envarsus on BK Viremia Incidence in Kidney Transplant Patients with Rapid Metabolism.

Authors :
Towns G
Agarwal G
Tamhane A
Kew C
Source :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2023 May 25; Vol. 29, pp. e939748. Date of Electronic Publication: 2023 May 25.
Publication Year :
2023

Abstract

BACKGROUND BK infections have been observed more frequently among people who are rapid metabolizers. The tacrolimus c/d ratio identifies rapid metabolizers after transplantation. Envarsus has a lower peak drug level exposure than tacrolimus and is more pronounced in rapid metabolizers. This study hypothesized that less exposure to high tacrolimus levels through use of Envarsus would reduce the incidence of BK infections. MATERIAL AND METHODS This study prospectively converted 43 consecutive kidney transplant recipients (identified as rapid metabolizers by c/d ratio of.

Details

Language :
English
ISSN :
1643-3750
Volume :
29
Database :
MEDLINE
Journal :
Medical science monitor : international medical journal of experimental and clinical research
Publication Type :
Academic Journal
Accession number :
37272339
Full Text :
https://doi.org/10.12659/MSM.939748